Article Information
History
- April 10, 2022.
Article Versions
- You are currently viewing Version 1 of this article (April 10, 2022 - 20:36).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Johannes Leiner, MD1,2,*,
- Vincent Pellissier, PhD1,
- Sven Hohenstein, PhD1,
- Sebastian König, MD1,2,
- Ekkehard Schuler, MD3,
- Robert Möller, MD3,
- Irit Nachtigall, MD3,
- Marzia Bonsignore, MD4,5,
- Gerhard Hindricks, MD1,2,
- Ralf Kuhlen, MD, PhD6 and
- Andreas Bollmann, MD, PhD1,2
- 1Leipzig Heart Institute, Leipzig, Germany
- 2Heart Center Leipzig at University of Leipzig, Department of Electrophysiology, Leipzig, Germany
- 3Helios Hospitals GmbH, Berlin, Germany
- 4Helios St. Anna Hospital, Department of Infectiology and Hospital Hygiene, Duisburg, Germany
- 5Institute for Medical Laboratory Diagnostics, Center for Clinical and Translational Research, Helios University Hospital Wuppertal, University of Witten/Herdecke, Wuppertal, Germany
- 6Helios Health GmbH, Berlin, Germany
- ↵*Corresponding author
Johannes Leiner, MD, Heart Center Leipzig at University of Leipzig, Department of Electrophysiology Russenstrasse 69A, 04289 Leipzig, Germany, E-Mail: johannes.leiner{at}helios-gesundheit.de, Phone: +49 341 865 251573
Posted April 10, 2022.
Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals
